Canadian Sec - Delayed Quote CAD

Pharmadrug Inc. (PHRX.CN)

0.0100
0.0000
(0.00%)
At close: June 13 at 10:08:06 AM EDT
Currency in CAD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
7.0090
Cost of Revenue
--
--
0
2.2630
9.1640
Gross Profit
--
--
0
-2.2630
-2.1550
Operating Expense
268.7560
668.6580
1,364.0770
2,488.4610
2,794.3400
Operating Income
-268.7560
-668.6580
-1,364.0770
-2,490.7240
-2,796.4950
Net Non Operating Interest Income Expense
-234.3400
-273.8680
-334.3460
-222.9340
-60.1290
Other Income Expense
54.0100
69.3710
-12,574.3490
-540.0490
-1,427.3500
Pretax Income
-449.0860
-873.1550
-14,272.7720
-3,254.0870
-4,283.9740
Tax Provision
0
0
-1,010.3440
-190
0
Net Income Common Stockholders
-396.3850
-793.2670
-13,201.3190
-8,875.6870
-5,873.5540
Diluted NI Available to Com Stockholders
-396.3850
-793.2670
-13,201.3190
-8,875.6870
-5,873.5540
Basic EPS
-0.00
-0.01
-0.23
-0.18
-0.01
Diluted EPS
-0.00
-0.01
-0.23
-0.18
-0.01
Basic Average Shares
107,143.6060
103,930.0300
56,487.7130
50,094.5340
47,311.6160
Diluted Average Shares
107,143.6060
103,930.0300
56,487.7130
50,094.5340
47,311.6160
Total Operating Income as Reported
--
-668.6580
-1,434.0770
--
--
Total Expenses
268.7560
668.6580
1,364.0770
2,490.7240
2,803.5040
Net Income from Continuing & Discontinued Operation
-396.3850
-793.2670
-13,201.3190
-8,875.6870
-5,873.5540
Normalized Income
-478.1030
-874.9850
-1,509.0322
-2,536.7486
-2,839.5840
Interest Income
--
--
0
62.7350
--
Interest Expense
234.3400
273.8680
334.3460
285.6690
60.1290
Net Interest Income
-234.3400
-273.8680
-334.3460
-222.9340
-60.1290
EBIT
-214.7460
-599.2870
-13,938.4260
-2,968.4180
-4,223.8450
EBITDA
-164.5020
-549.0430
-13,912.2100
-2,947.3900
-4,207.8270
Reconciled Cost of Revenue
--
--
0
2.2630
9.1640
Reconciled Depreciation
50.2440
50.2440
26.2160
21.0280
16.0180
Net Income from Continuing Operation Net Minority Interest
-396.3850
-793.2670
-13,201.3190
-3,064.0870
-4,283.9740
Total Unusual Items Excluding Goodwill
81.7180
81.7180
-12,583.0160
-560.0380
-1,444.3900
Total Unusual Items
81.7180
81.7180
-12,583.0160
-560.0380
-1,444.3900
Normalized EBITDA
-246.2200
-630.7610
-1,329.1940
-2,387.3520
-2,763.4370
Tax Rate for Calcs
0
0
0.0001
0.0001
0
Tax Effect of Unusual Items
0
0
-890.7292
-32.6996
0
12/31/2021 - 1/31/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers